Efficacy News and Research

RSS

How virtual reality transforms women’s labor experiences

A PLOS ONE study found that virtual reality (VR) effectively reduces labor pain and anxiety, providing a positive and immersive birthing experience for women.

17 Jun 2024

Understanding salivary gland microenvironment to advance Sjögren's disease treatment

TLS are accumulations of lymphoid cells that share similar cellular compartments, organization, and function as secondary lymphoid organs. Importantly, the presence of these structures in inflamed salivary glands associated with active disease, increased autoantibody production, and malignancy risk.

16 Jun 2024

Promising gene editing therapy shows hope in sickle cell disease cure

Researchers have presented the latest findings from a clinical trial aimed at discovering a cure for sickle cell disease, a painful genetic blood disorder with limited treatment options.

14 Jun 2024

Innovative 3D cell culturing method offers new insights into cancer cell mechanics

Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials.

14 Jun 2024

Physical activity and cognitive training can improve mood for adults with Down's syndrome

A new study has discovered that physical activity and cognitive training can improve levels of life satisfaction and mood for adults with Down's syndrome.

13 Jun 2024

Study demonstrates efficacy of treat-to-target in early axial spondyloarthritis

Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR - The European Alliance of Associations for Rheumatology - recommends early intervention in arthritis, since conventional synthetic disease-modifying antirheumatic drugs (csDMARD) have been shown to slow disease progression in both rheumatoid and psoriatic arthritis.

13 Jun 2024

Research points to a potential approach to mitigating diabetes risk from antipsychotic medications

New University of Pittsburgh research points to a potential approach to reducing the risk of diabetes associated with widely prescribed antipsychotic medications.

13 Jun 2024

MEK inhibitor trametinib shows potential in pediatric JMML treatment

The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic leukemia (JMML) enrolled in a phase II clinical trial, with seven of 10 patients alive after a median of two years.

13 Jun 2024

Combining donepezil and memantine extends lives of Alzheimer's patients, study finds

Alzheimer's disease is the world's most common neurodegenerative disease, affecting more than 50 million people globally.

12 Jun 2024

Deep learning revives ancient peptides to battle antibiotic resistance

Researchers used deep learning to resurrect antibiotic peptides from extinct organisms, offering new solutions for combating antibiotic resistance.

12 Jun 2024

UC San Diego engineers develop algae-based microrobots for lung cancer treatment

Engineers at the University of California San Diego have developed microscopic robots, known as microrobots, capable of swimming through the lungs to deliver cancer-fighting medication directly to metastatic tumors.

12 Jun 2024

UNF researchers awarded U.S. patent for targeted cancer-fighting compound

Three University of North Florida (UNF) researchers have been awarded a U.S. patent for a targeted cancer-fighting compound, or peptoid, that the team has discovered targets certain breast, colon and lung cancers and stops them from progressing.

12 Jun 2024

Nutrients deficiency pattern possible important risk factor for mortality in older adults with hypertension

Researchers determine the impact of nutrient deficiencies on mortality risk in older adults with hypertension.

12 Jun 2024

Enhancing CAR-T cell therapy with biodegradable scaffolds

CAR-T cell therapies are transforming the treatment of previously incurable blood cancers. Six approved CAR-T products have been administered to more than 20,000 people, and more than 500 clinical trials are underway.

12 Jun 2024

Combining anlotinib with STUPP regimen improves survival in glioblastoma patients

Glioblastoma multiforme (GBM) is among the most aggressive forms of brain tumors, with few effective treatment options and a bleak prognosis.

12 Jun 2024

First-in-human trial shows safety and efficacy of CAR T cell therapy for advanced prostate cancer

Treating prostate cancer with immunotherapy is currently difficult to do. But results from a first in-human phase 1 trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States, showed that patients with advanced prostate cancer can be treated safely with the cellular immunotherapy with promising therapeutic activity, according to the phase 1 trial study published today in Nature Medicine.

12 Jun 2024

Human antibodies show promise against Black widow spider venom

1
2
3
4
...
1194
Next

Efficacy News and Research

How virtual reality transforms women’s labor experiences

Understanding salivary gland microenvironment to advance Sjögren's disease treatment

Promising gene editing therapy shows hope in sickle cell disease cure

Innovative 3D cell culturing method offers new insights into cancer cell mechanics

Physical activity and cognitive training can improve mood for adults with Down's syndrome

Study demonstrates efficacy of treat-to-target in early axial spondyloarthritis

Research points to a potential approach to mitigating diabetes risk from antipsychotic medications

MEK inhibitor trametinib shows potential in pediatric JMML treatment

Combining donepezil and memantine extends lives of Alzheimer's patients, study finds

Deep learning revives ancient peptides to battle antibiotic resistance

UC San Diego engineers develop algae-based microrobots for lung cancer treatment

UNF researchers awarded U.S. patent for targeted cancer-fighting compound

Nutrients deficiency pattern possible important risk factor for mortality in older adults with hypertension

Enhancing CAR-T cell therapy with biodegradable scaffolds

Combining anlotinib with STUPP regimen improves survival in glioblastoma patients

First-in-human trial shows safety and efficacy of CAR T cell therapy for advanced prostate cancer

Human antibodies show promise against Black widow spider venom

Natural antioxidants could delay age-related decline in male testosterone production

AI revolutionizes malaria diagnosis with 97.57% accuracy using EfficientNet

Study finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody response

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News